Pathology, research and practiceHumansArthritisRheumatoidAntirheumatic AgentsBiological Products
New frontiers in rheumatoid arthritis therapy: From classic DMARDs to biologics and beyond.
Vanshika, Puja Gulati, Ritika Thakur, Deeksha Bala, Richa Bajaj, Priya, Chetan Bansal, Tamanna Dhiman, Inderjeet Verma, Shivani Pannu
Published: 202610.1016/j.prp.2025.156307
Abstract
Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disorder identified by persistent synovial inflammation, joint destruction, and systemic complications. Affecting approximately 0.5-1 % of the global population, RA poses a considerable burd…
Preview only. Read the full abstract at the source